BMC Cancer Q2
Unclaimed
BioMed Central Ltd.
United Kingdom
BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 129. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1,358 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,358.
BMC Cancer focuses its scope in these topics and keywords: cancer, breast, patients, cell, human, ovarian, study, expression, cells, growth, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Price
2390 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,358
SJR Impact factor129
H Index1205
Total Docs (Last Year)3427
Total Docs (3 years)45155
Total Refs14037
Total Cites (3 years)3423
Citable Docs (3 years)4,07
Cites/Doc (2 years)37,47
Ref/DocOther journals with similar parameters
Heredity Q2
American Journal of Medical Genetics, Part C: Seminars in Medical Genetics Q2
American Journal of Medical Genetics - Seminars in Medical Genetics Q2
Frontiers in Genetics Q2
Journal of Genetics and Genomics Q2
Compare this journals
Comments